Please use this identifier to cite or link to this item: https://hdl.handle.net/10316/108895
DC FieldValueLanguage
dc.contributor.authorBranco, Jaime C.-
dc.contributor.authorRodrigues, Ana M.-
dc.contributor.authorGouveia, Nélia-
dc.contributor.authorEusébio, Mónica-
dc.contributor.authorRamiro, Sofia-
dc.contributor.authorMachado, Pedro-
dc.contributor.authorda Costa, Leonor Pereira-
dc.contributor.authorMourão, Ana Filipa-
dc.contributor.authorSilva, Inês-
dc.contributor.authorLaires, Pedro-
dc.contributor.authorSepriano, Alexandre-
dc.contributor.authorAraújo, Filipe-
dc.contributor.authorGonçalves, Sónia-
dc.contributor.authorCoelho, Pedro S.-
dc.contributor.authorTavares, Viviana-
dc.contributor.authorCerol, Jorge-
dc.contributor.authorMendes, Jorge M.-
dc.contributor.authorCarmona, Loreto-
dc.contributor.authorCanhão, Helena-
dc.date.accessioned2023-09-22T10:46:31Z-
dc.date.available2023-09-22T10:46:31Z-
dc.date.issued2016-
dc.identifier.issn2056-5933pt
dc.identifier.urihttps://hdl.handle.net/10316/108895-
dc.description.abstractObjectives: To estimate the national prevalence of rheumatic and musculoskeletal diseases (RMDs) in the adult Portuguese population and to determine their impact on health-related quality of life (HRQoL), physical function, anxiety and depression. Methods: EpiReumaPt is a national health survey with a three-stage approach. First, 10 661 adult participants were randomly selected. Trained interviewers undertook structured face-to-face questionnaires that included screening for RMDs and assessments of health-related quality of life, physical function, anxiety and depression. Second, positive screenings for ≥1 RMD plus 20% negative screenings were invited to be evaluated by a rheumatologist. Finally, three rheumatologists revised all the information and confirmed the diagnoses according to validated criteria. Estimates were computed as weighted proportions, taking the sampling design into account. Results: The disease-specific prevalence rates (and 95% CIs) of RMDs in the adult Portuguese population were: low back pain, 26.4% (23.3% to 29.5%); periarticular disease, 15.8% (13.5% to 18.0%); knee osteoarthritis (OA), 12.4% (11.0% to 13.8%); osteoporosis, 10.2% (9.0% to 11.3%); hand OA, 8.7% (7.5% to 9.9%); hip OA, 2.9% (2.3% to 3.6%); fibromyalgia, 1.7% (1.1% to 2.1%); spondyloarthritis, 1.6% (1.2% to 2.1%); gout, 1.3% (1.0% to 1.6%); rheumatoid arthritis, 0.7% (0.5% to 0.9%); systemic lupus erythaematosus, 0.1% (0.1% to 0.2%) and polymyalgia rheumatica, 0.1% (0.0% to 0.2%). After multivariable adjustment, participants with RMDs had significantly lower EQ5D scores (β=−0.09; p<0.001) and higher HAQ scores (β=0.13; p<0.001) than participants without RMDs. RMDs were also significantly associated with the presence of anxiety symptoms (OR=3.5; p=0.006). Conclusions: RMDs are highly prevalent in Portugal and are associated not only with significant physical function and mental health impairment but also with poor HRQoL, leading to more health resource consumption. The EpiReumaPt study emphasises the burden of RMDs in Portugal and the need to increase RMD awareness, being a strong argument to encourage policymakers to increase the amount of resources allocated to the treatment of rheumatic patients.pt
dc.language.isoengpt
dc.publisherBMJ Publishing Grouppt
dc.relationEpiReumaPt was supported by a grant from Direcção-Geral da Saúde and was sponsored by: Fundação Calouste Gulbenkian, Fundação Champalimaud, Fundação AstraZeneca, Abbott, Merck Sharp & Dohme, Pfizer, Roche, Servier, Bial, D3A Medical Systems, Happybrands, Centro de Medicina Laboratorial Germano de Sousa, CAL-Clínica, Galp Energia, Açoreana Seguros and individual Rheumatologists.pt
dc.rightsopenAccesspt
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/pt
dc.subjectEpidemiologypt
dc.subjectFibromyalgis/Pain Syndromespt
dc.subjectLow Back Painpt
dc.subjectOsteoarthritispt
dc.subjectSpondyloarthritispt
dc.titlePrevalence of rheumatic and musculoskeletal diseases and their impact on health-related quality of life, physical function and mental health in Portugal: results from EpiReumaPt- a national health surveypt
dc.typearticle-
degois.publication.firstPagee000166pt
degois.publication.issue1pt
degois.publication.titleRMD Openpt
dc.peerreviewedyespt
dc.identifier.doi10.1136/rmdopen-2015-000166pt
degois.publication.volume2pt
dc.date.embargo2016-01-01*
uc.date.periodoEmbargo0pt
item.grantfulltextopen-
item.cerifentitytypePublications-
item.languageiso639-1en-
item.openairetypearticle-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextCom Texto completo-
crisitem.author.researchunitCNC - Center for Neuroscience and Cell Biology-
crisitem.author.orcid0000-0002-8411-7972-
crisitem.author.orcid0000-0001-7133-6386-
Appears in Collections:FMUC Medicina - Artigos em Revistas Internacionais
Show simple item record

Page view(s)

50
checked on May 8, 2024

Download(s)

27
checked on May 8, 2024

Google ScholarTM

Check

Altmetric

Altmetric


This item is licensed under a Creative Commons License Creative Commons